During the past decade, Beneficencia Portuguesa de Sao Paulo conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 6 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 5 clinical trials were completed. i.e. 12.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beneficencia Portuguesa de Sao Paulo" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Latin American Cooperative Oncology Group" with 10 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Hospital Israelita Albert Einstein" with 4 trials sponsored and "Hospital do Coracao" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beneficencia Portuguesa de Sao Paulo" #1 collaborator was "Hospital Israelita Albert Einstein" with 4 trials as a collaborator, "Hospital Moinhos de Vento" with 4 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 3 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 3 trials as a collaborator and "Hospital do Coracao" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Beneficencia Portuguesa de Sao Paulo" are "Coronary Artery Disease" (3 trials), "Multiple Myeloma" (3 trials), "Prostate Cancer" (3 trials), "Acute Respiratory Distress Syndrome" (2 trials) and "COVID-19 Pneumonia" (2 trials). Many other conditions were trialed in "Beneficencia Portuguesa de Sao Paulo" in a lesser frequency.

Most popular intervention types in "Beneficencia Portuguesa de Sao Paulo" are "Drug" (41 trials), "Other" (10 trials), "Biological" (2 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Atezolizumab" (5 trials), "Dexamethasone" (4 trials), "Bortezomib" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beneficencia Portuguesa de Sao Paulo" are 49 trials for "All" genders, 6 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Beneficencia Portuguesa de Sao Paulo". undefined are not yet recruiting, 26 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Beneficencia Portuguesa de Sao Paulo, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Beneficencia Portuguesa de Sao Paulo, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".